Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference
SAN MATEO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company ...
Knowridge4 天
This drug can treat fatty liver disease and obesity
Liver disease affects millions of adults in the United States, posing serious risks to health if left untreated. Among the ...
Six critical signs of fatty liver disease you shouldn’t ignore
With an estimated two billion people affected worldwide, fatty liver disease is a silent epidemic that often goes unnoticed ...
PharmaTimes6 天
FDA approves Sequana Medical’s Alfapump for ascites treatment
Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...